Cellavision Ab Ord
- Company typePublic
- Founded1994
- HeadquartersLund, Sweden
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Cellavision Ab Ord firmographics
Firmographics- Name
- Cellavision Ab Ord
- Legal name
- CellaVision AB (publ)
- Website
- https://cellavision.com
- Company type
- Public
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Cellavision Ab Ord industry classification
Industry- Product category
- Digital Hematology Microscopy and Cell Morphology
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industries
- Flow Cytometry & Cellular Analysis Diagnostics (HLAHAAAF), Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
Keywords
Where Cellavision Ab Ord is headquartered
LocationHeadquarters
- HQ city
- Lund
- HQ country
- Sweden
- HQ region
- Europe
Offices4 records
Markets served
Cellavision Ab Ord business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
Revenue model
- Hardware - Analyzers: Sale of digital cell morphology analyzers including CellaVision DC-1, DM1200, and DM9600. Analyzer manufacturing is outsourced in Sweden. One-time hardware purchase model with ongoing software and reagent needs.
- Software Licenses and Subscriptions: Software applications including Peripheral Blood Application, Advanced RBC Application, Body Fluid Application, Bone Marrow Aspirate Application, Review Software, and Server Software. Likely subscription or perpetual license model with annual maintenance/support.
- Reagents: Stains and reagents for hematology including RAL Diagnostics branded products. Reagent manufacturing performed in-house at Bordeaux, France facility. Covers automated staining, manual staining, hematology, microbiology, cytology, and histology applications.
- Training and Certification Services: CellaVision Academy provides certification programs for service engineers and applications specialists. Includes self-paced e-learning, instructor-led courses, and 'Ask the Expert' monthly sessions. Free for distribution partners.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels9 records
Cellavision Ab Ord product offering
Product offeringCore offering
CellaVision develops and sells digital cell morphology systems for routine analysis of blood and other body fluids in hematology laboratories. Its offering combines digital microscopy analyzers, AI-powered software applications for cell pre-classification, staining instruments, and reagents, replacing traditional manual microscopy with automated workflows for peripheral blood, bone marrow aspirate, red blood cells, and body fluid analysis. The company serves hospital laboratories, reference laboratories, and veterinary labs globally.
Product overview
CellaVision offers a unified platform-plus-modules architecture for digital hematology microscopy. The core consists of hardware analyzers (DC-1, DM1200, DM9600) and the Digital Cell Morphology Software that work together to automate blood cell morphology analysis. Software modules extend the platform: the Peripheral Blood Application handles routine differentials, the Advanced RBC Application analyzes red cells, the Body Fluid Application covers non-blood samples, and the Bone Marrow Aspirate Application (recently launched 2026) addresses complex bone marrow analysis. The Review Software and Server Software enable remote collaboration across laboratory networks. Supporting infrastructure includes RAL StainBox and RAL Stainer instruments, RAL Diagnostics reagents, and educational tools (CellAtlas, Proficiency Software). The Sysmex partnership extends market reach for the BMA Application. Over 9,500 analyzer units have been sold globally.
Differentiator
Problem solved
Functional benefit
Brands
- RAL Diagnostics: Stains and reagents brand for hematology diagnostics, including RAL Stainer and RAL StainBox products
- DIFF-Line
- CellAtlas
- CellaVision Proficiency Software
Products and services
- CellaVision DC-1 Analyzer Compact digital hematology analyzer that automatically scans and captures images of blood cell samples for digital morphology analysis. Supports both peripheral blood and bone marrow analysis on one integrated platform with genuine 100x magnification.
- CellaVision DM1200 Analyzer Digital hematology analyzer for medium to large laboratories, supporting automated blood cell morphology analysis.
- CellaVision DM9600 Analyzer
- DIFF-Line by CellaVision
- RAL StainBox
- RAL Stainer
- CellaVision Bone Marrow Aspirate Application AI-powered digital workflow application for bone marrow morphology analysis. Automatically locates analysis areas, captures high-resolution images, and pre-classifies nucleated cells into 17 cell types. CE marked as Class C device under EU IVDR.
- CellaVision Peripheral Blood Application
- CellaVision Advanced RBC Application
- CellaVision Body Fluid Application
- CellaVision Review Software
- CellaVision Server Software
- CellaVision Scanner Application
- CellaVision VET
- CellaVision Digital Cell Morphology Software 7.2 Major software release featuring processing up to 45 slides per hour on DI-60 analyzers (serial number 70000+), new modern GUI, enhanced microscopy with cooler color balance, split view comparison tools for patient results, RBC analysis improvements, multi-user discussions and commenting, and Central QC review for DC-1 analyzers.
- RAL Diagnostics Reagents
- CellaVision Proficiency Software
- CellaVision CellAtlas Educational blood cell encyclopedia and morphology reference tool featuring comprehensive cell images, interactive hematopoiesis flowchart, and blood cell quizzes. Available as web application and mobile app.
Quantifiable outcome
- Processes up to 45 slides per hour with Software 7.2 (DI-60 with serial number 70000+)
- +4 more outcomes
Companies that use Cellavision Ab Ord
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
Cellavision Ab Ord technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability3 records
Feature7 records
Cellavision Ab Ord partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sysmex CorporationcoreSysmex is the distribution partner for the CellaVision Bone Marrow Aspirate (BMA) Application across the EMEA region. Sysmex holds the highest global market share in the large hematology segment, providing broad market reach and established relationships with hospital and reference laboratories. The partnership leverages Sysmex's distribution network for the BMA product launch in Europe.
Scale indicators13 records
Recent moves8 records
Expansion highlights5 records
Cellavision Ab Ord competitors and assessment
Company assessmentDirect peers
- HORIBA Medical: Manufacturer of hematology analyzers (ABX / Yumizen lines) and a direct competitor to CellaVision in mid- and large-volume hematology laboratories globally, particularly in European and emerging markets.
- Sysmex Corporation: Global leader in hematology and hemostasis analyzers and CellaVision's exclusive EMEA distribution partner for the Bone Marrow Aspirate Application. Both companies target hematology laboratories and increasingly compete/collaborate in digital cell morphology workflows.
Broad incumbents
- Roche Diagnostics: Global IVD incumbent with hematology and digital diagnostics products (cobas line) sold into hospital and reference laboratories. Represents both a competitive threat via integrated workflows and a potential partnership/benchmark for CellaVision's AI diagnostics.
- Hologic (CytoVision): Through its CytoVision product line, Hologic offers digital chromosome and cytogenetics imaging systems used in hematology/cancer diagnostics workflows — adjacent but comparable digital microscopy applications serving similar clinical laboratory customers.
- Siemens Healthineers: Broad diagnostics portfolio including hematology analyzers (Atellica / ADVIA lines) and laboratory automation sold to the same large hospital and reference laboratory customers CellaVision serves, often as part of integrated chemistry/immunoassay/hematology bids.
- Abbott Diagnostics: Multi-modality diagnostics company with hematology and core laboratory solutions serving large hospital networks and reference labs — the same enterprise buyer CellaVision targets with its digital morphology platform.
- Beckman Coulter (Danaher): Major hematology analyzer manufacturer under Danaher's diagnostics platform, offering integrated cell analysis and laboratory automation workflows to large hospital and reference lab customers that overlap with CellaVision's enterprise target market.
Emerging players
- Scopio Labs: Israeli digital cell morphology startup applying AI and full-field imaging to peripheral blood and bone marrow analysis. Direct emerging competitor to CellaVision's core digital morphology platform and a potential disruptor to its installed base.
- Mindray Bio-Medical: Chinese medical device company rapidly expanding in hematology analyzers and laboratory automation, competing on price-performance in emerging markets where CellaVision also seeks growth (China, India, Brazil).
Regional players
- Nihon Kohden: Japanese medical device company with strong presence in hematology analyzers across APAC, particularly Japan, and serves the same regional customer base as CellaVision's APAC commercial footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Cellavision Ab Ord social profiles
Digital presenceCellavision Ab Ord compliance and trust
Trust signalCompliance1 record
Cellavision Ab Ord financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cellavision Ab Ord leadership team
Management profileNumber of profiles
Profiles8 records
Cellavision Ab Ord subsidiaries and ownership
Company hierarchySubsidiaries1 record
Cellavision Ab Ord funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cellavision Ab Ord M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cellavision Ab Ord
What does Cellavision Ab Ord do?
CellaVision develops and sells digital cell morphology systems for routine analysis of blood and other body fluids in hematology laboratories. Its offering combines digital microscopy analyzers, AI-powered software applications for cell pre-classification, staining instruments, and reagents, replacing traditional manual microscopy with automated workflows for peripheral blood, bone marrow aspirate, red blood cells, and body fluid analysis. The company serves hospital laboratories, reference laboratories, and veterinary labs globally.
Is Cellavision Ab Ord a public or private company?
Cellavision Ab Ord is a public company. It is classified as public and is currently operating.
When was Cellavision Ab Ord founded?
Cellavision Ab Ord was founded in 1994. It employs 101 to 250 people.
Where is Cellavision Ab Ord based?
Cellavision Ab Ord is headquartered in Lund, Sweden, in the Europe region.
How does Cellavision Ab Ord make money?
Four revenue lines are on record. Hardware - Analyzers are the primary driver. The others are software Licenses and Subscriptions, reagents and training and Certification Services.
Who are Cellavision Ab Ord's main competitors?
Direct peers on record are HORIBA Medical and Sysmex Corporation. Broad incumbents are Roche Diagnostics, Hologic (CytoVision), Siemens Healthineers, Abbott Diagnostics and Beckman Coulter (Danaher). Emerging players are Scopio Labs and Mindray Bio-Medical. Nihon Kohden is listed as a regional player.
Does Cellavision Ab Ord have an API?
No public API is recorded for Cellavision Ab Ord.
What industry is Cellavision Ab Ord in?
Cellavision Ab Ord's product category is Digital Hematology Microscopy and Cell Morphology. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAHAAAF, Flow Cytometry & Cellular Analysis Diagnostics. Its NAICS code is 334516 and its SIC code is 3826.